112 related articles for article (PubMed ID: 17220557)
1. Amifostine improves hemodynamic parameters in doxorubicin-pretreated rabbits.
Potemski P; Polakowski P; Wiktorowska-Owczarek AK; Owczarek J; Płuzańska A; Orszulak-Michalak D
Pharmacol Rep; 2006; 58(6):966-72. PubMed ID: 17220557
[TBL] [Abstract][Full Text] [Related]
2. Influence of carnosine on the cardiotoxicity of doxorubicin in rabbits.
Zieba R; Wagrowska-Danilewicz M
Pol J Pharmacol; 2003; 55(6):1079-87. PubMed ID: 14730104
[TBL] [Abstract][Full Text] [Related]
3. Efficiency of amifostine as a protection against doxorubicin toxicity in rats during a 12-day treatment.
Nazeyrollas P; Frances C; Prevost A; Costa B; Lorenzato M; Kantelip JP; Elaerts J; Millart H
Anticancer Res; 2003; 23(1A):405-9. PubMed ID: 12680240
[TBL] [Abstract][Full Text] [Related]
4. Comparison of the protective effects of amifostine and dexrazoxane against the toxicity of doxorubicin in spontaneously hypertensive rats.
Herman EH; Zhang J; Chadwick DP; Ferrans VJ
Cancer Chemother Pharmacol; 2000; 45(4):329-34. PubMed ID: 10755322
[TBL] [Abstract][Full Text] [Related]
5. Investigation of doxorubicin tissue toxicity: does amifostine provide chemoprotection? An experimental study.
Rigatos SK; Stathopoulos GP; Dontas I; Perrea-Kotsarelis D; Couris E; Karayannacos PE; Deliconstantinos G
Anticancer Res; 2002; 22(1A):129-34. PubMed ID: 12017274
[TBL] [Abstract][Full Text] [Related]
6. Effects of amifostine on perfused isolated rat heart and on acute doxorubicin-induced cardiotoxicity.
Nazeyrollas P; Prévost A; Baccard N; Manot L; Devillier P; Millart H
Cancer Chemother Pharmacol; 1999; 43(3):227-32. PubMed ID: 9923553
[TBL] [Abstract][Full Text] [Related]
7. The protective effects of amifostine on adriamycin-induced acute cardiotoxicity in rats.
Bolaman Z; Cicek C; Kadikoylu G; Barutca S; Serter M; Yenisey C; Alper G
Tohoku J Exp Med; 2005 Dec; 207(4):249-53. PubMed ID: 16272794
[TBL] [Abstract][Full Text] [Related]
8. The Efficacy of Amifostine against Multiple-Dose Doxorubicin-Induced Toxicity in Rats.
Jaćević V; Dragojević-Simić V; Tatomirović Ž; Dobrić S; Bokonjić D; Kovačević A; Nepovimova E; Vališ M; Kuča K
Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30103540
[TBL] [Abstract][Full Text] [Related]
9. Does combined single intravenous injection of doxorubicin and verapamil have any influence on hemodynamic parameters in rabbits?
Stepień M; Drzewoski J
Mater Med Pol; 1995; 27(1):19-22. PubMed ID: 8569271
[TBL] [Abstract][Full Text] [Related]
10. The effects of N omega-nitro-L-arginine methyl ester, sodium nitroprusside and noradrenaline on venous return in the anaesthetized cat.
Bower EA; Law AC
Br J Pharmacol; 1993 Apr; 108(4):933-40. PubMed ID: 8485632
[TBL] [Abstract][Full Text] [Related]
11. Amifostine protects against early but not late toxic effects of doxorubicin in infant rats.
Jahnukainen K; Jahnukainen T; Salmi TT; Svechnikov K; Eksborg S; Söder O
Cancer Res; 2001 Sep; 61(17):6423-7. PubMed ID: 11522636
[TBL] [Abstract][Full Text] [Related]
12. Salivary gland protection by S-2-(3-aminopropylamino)-ethylphosphorothioic acid (amifostine) in high-dose radioiodine treatment: results obtained in a rabbit animal model and in a double-blind multi-arm trial.
Bohuslavizki KH; Klutmann S; Jenicke L; Kröger S; Buchert R; Mester J; Clausen M
Cancer Biother Radiopharm; 1999 Oct; 14(5):337-47. PubMed ID: 10850318
[TBL] [Abstract][Full Text] [Related]
13. Effects of dexrazoxane and amifostine on evolution of Doxorubicin cardiomyopathy in vivo.
Bjelogrlic SK; Radic J; Radulovic S; Jokanovic M; Jovic V
Exp Biol Med (Maywood); 2007 Dec; 232(11):1414-24. PubMed ID: 18040065
[TBL] [Abstract][Full Text] [Related]
14. The acute effect of doxorubicin and its analogue--4'-epidoxorubicin on circulatory system in rabbits.
Drzewoski J; Polakowski P; Kaszubski P; Orszulak-Michalak D
Pol J Pharmacol Pharm; 1988; 40(2):159-65. PubMed ID: 3237565
[TBL] [Abstract][Full Text] [Related]
15. The vasoconstrictor effects of L-NAME, a nitric oxide synthase inhibitor, in pregnant rabbits.
Losonczy G; Mucha I; Müller V; Kriston T; Ungvári Z; Tornóci L; Rosivall L; Venuto R
Br J Pharmacol; 1996 Jun; 118(4):1012-8. PubMed ID: 8799576
[TBL] [Abstract][Full Text] [Related]
16. Histopathological and scintigraphic comparisons of the protective effects of L-carnitine and amifostine against radiation-induced late renal toxicity in rats.
Caloglu M; Yurut-Caloglu V; Durmus-Altun G; Oz-Puyan F; Ustun F; Cosar-Alas R; Saynak M; Parlar S; Turan FN; Uzal C
Clin Exp Pharmacol Physiol; 2009 May; 36(5-6):523-30. PubMed ID: 19673935
[TBL] [Abstract][Full Text] [Related]
17. Effects of amifostine on glycerol-pretreated rabbit kidneys.
Barun S; Ertoy D; Dileköz E; Müftüoglu S; Erten Y; Sucak G; Bali M; Tekeli N; Sarioglu Y; Ercan ZS
Basic Clin Pharmacol Toxicol; 2005 Sep; 97(3):168-73. PubMed ID: 16128911
[TBL] [Abstract][Full Text] [Related]
18. Radiopharmaceutical model using 99mTc-MIBI to evaluate amifostine protection against doxorubicin cardiotoxicity in rats.
Yurekli Y; Unak P; Ertay T; Biber Z; Medine I; Teksoz S
Ann Nucl Med; 2005 May; 19(3):197-200. PubMed ID: 15981672
[TBL] [Abstract][Full Text] [Related]
19. The protective activity of ICRF-187 against doxorubicin-induced cardiotoxicity in the rat.
Yeung TK; Jaenke RS; Wilding D; Creighton AM; Hopewell JW
Cancer Chemother Pharmacol; 1992; 30(1):58-64. PubMed ID: 1586981
[TBL] [Abstract][Full Text] [Related]
20. Cardiac and hemodynamic responses to synthetic atrial natriuretic factor in rats.
Seymour AA; Sweet CS; Stabilito II; Emmert SE
Life Sci; 1987 Feb; 40(6):511-9. PubMed ID: 2949128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
